Abstract
Primary tumours secrete many cytokines and chemokines including CCL2, VEGF, TNFα, and TGF-β. In the natural course of primary tumour growth, these factors stimulate bone marrow cells and tissue-resident cells including immune cells and endothelial cells in the distant host tissues. Despite ubiquitously spreading in blood vessels, the secreted factors from primary tumours mediate discrete hyperpermeability foci by several overlapping cascades such as S100A8-SAA3-TLR4/MD-2 and VEGF-FAK-E-selectin. The former is that these secreted factors stimulate CCR2 in potentially hyperpermeable areas, further inducing the secretion of SAA3 and S100A8, which increase vascular permeability via TLR4/MD-2. The latter is that tumour-derived VEGF generates the permeable foci with E-selectin upregulation through endothelial FAK in the premetastatic lungs. Blocking the cascade of the permeability in hyperpermeability regions before metastasis results in the reduction of tumour cell homing. Thus, it is an advantage to target very early metastatic or premetastatic phase.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932–936
Couzin J (2003) Medicine. Tracing the steps of metastasis, cancer’s menacing ballet. Science 299:1002–1006
ELICEIRI BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA (2002) Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol 157:149–160
Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15:35–44
Ferrara N, Gerber HP, Lecouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679–695
Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massague J (2007) Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765–770
Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289–300
Hiratsuka S, Watanabe A, Aburatani H, Maru Y (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8:1369–1375
Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10:1349–1355
Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG, Jain RK (2011) Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci U S A 108:3725–3730
Hiratsuka S, Ishibashi S, Tomita T, Watanabe A, Akashi-Takamura S, Murakami M, Kijima H, Miyake K, Aburatani H, Maru Y (2013) Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun 4:1853
Huang Y, Song N, Ding Y, Yuan S, Li X, Cai H, Shi H, Luo Y (2009) Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res 69:7529–7537
Hynes RO (2003) Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113:821–823
Jaklitsch MT, Mery CM, Lukanich JM, Richards WG, Bueno R, Swanson SJ, Mentzer SJ, Davis BD, Allred EN, Sugarbaker DJ (2001) Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest. J Thorac Cardiovasc Surg 121:657–667
Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, Macdonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827
Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102–106
Mostert B, Sleijfer S, Foekens JA, Gratama JW (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35:463–474
Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11:109–119
Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571–573
Riethdorf S, Pantel K (2008) Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 75:140–148
Schlappack OK, Baur M, Steger G, Dittrich C, Moser K (1988) The clinical course of lung metastases from breast cancer. J Mol Med 66:790–795
Tyagi N, Roberts AM, Dean WL, Tyagi SC, Lominadze D (2008) Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 307:13–22
Wygrecka M, Jablonska E, Guenther A, Preissner KT, Markart P (2008) Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 99:494–501
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Hiratsuka, S. (2016). Establishment of Diagnosis for Early Metastasis. In: Miyasaka, M., Takatsu, K. (eds) Chronic Inflammation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56068-5_16
Download citation
DOI: https://doi.org/10.1007/978-4-431-56068-5_16
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56066-1
Online ISBN: 978-4-431-56068-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)